Dr. Alexander M. Lesokhin, MD
- Medicare services, 2024
- 900
- Medicare patients, 2024
- 241
- Part D claims, 2024
- 1,079
- Publications
- 143
- Clinical trials
- 9
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Lesokhin's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Alexander M. Lesokhin is a hematologist and oncologist in New York, New York
Dr. Lesokhin practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Lesokhin's NPI, 1790950863, was assigned on April 29, 2008. Dr. Lesokhin graduated from Albert Einstein College of Medicine in 2002. Dr. Lesokhin holds New York license 231760.
- NPI
- 1790950863NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7416018528
- NPI enumeration date
- April 29, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Alexander M. Lesokhin practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Lesokhin's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Alexander M. Lesokhin is affiliated with 1 site of care and 3 medical groups
Dr. Lesokhin's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Hematology Lymphoma Group. Dmand AI also links Dr. Lesokhin to 2 more medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Alexander M. Lesokhin's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lesokhin practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Alexander M. Lesokhin is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Lesokhin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lesokhin is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Lesokhin's licenses on file in 4 states: New York, Florida, New Jersey and North Carolina.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
- Florida license
- New Jersey license
- North Carolina license
Clinical focus
Dmand AI lists breast cancer, chronic leukemia, multiple myeloma and prostate cancer among the conditions Dr. Lesokhin treats.
Hematologists and oncologists near Dr. Lesokhin
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Alexander M. Lesokhin billed Medicare for 900 services in 2024
CMS data shows 900 Medicare services from Dr. Lesokhin across 7 procedure codes in 2024, for 241 Medicare patients. Medicare paid $87,362 for them.
Dr. Lesokhin's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 6552024: 82125%
- Other services
- 2023: 02024: 79
Where Dr. Lesokhin's Medicare services took place, 2024
- In an office74182%
- In a facility15918%
Dr. Lesokhin compared with the New York median for hematologists and oncologists, 2024
- Dr. Lesokhin
- New York median
- Medicare services
- 900vs 66835% above
- Medicare patients
- 241vs 21015% above
- Part D claims
- 922vs 2583.6 times
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Lesokhin's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lesokhin?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lesokhin and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Alexander M. Lesokhin treated 241 Medicare patients in 2024, average age 75
CMS counts 241 Medicare patients who saw Dr. Lesokhin in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Lesokhin's median patient age at 73, with 44% women.
Dr. Lesokhin's Medicare patients by age, 2024
Dr. Lesokhin's Medicare patients by sex, 2024
- Women10945%
- Men13255%
Chronic conditions among Dr. Lesokhin's Medicare patients, 2024
- High blood pressure75%
- High cholesterol73%
- Arthritis55%
- Ischemic heart disease40%
- Chronic kidney disease36%
- Mood disorders32%
- Anxiety31%
- Diabetes31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Lesokhin's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women44%
- Men55%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Alexander M. Lesokhin wrote 1,079 Medicare Part D claims in 2024
In 2024, Dr. Lesokhin wrote 1,079 Medicare Part D claims for 154 patients. 80% of them were for generic drugs. CMS names the drug for 922 of them, across 25 drugs with 11 or more claims each, at $3,307,393 in total drug cost. In 2023, CMS named 646 claims across 21 drugs.
Dr. Lesokhin's Part D claims by kind of drug, 2024
- Generic864 claims80%
- Brand-name and other215 claims20%
Dr. Lesokhin's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Lesokhin's Part D claims, 2024
- Opioids7%75 of 1,079 claims
- Antibiotics8%89 of 1,079 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6462024: 92243%
Drugs named by CMS: 25 in 2024, 21 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Alexander M. Lesokhin scored 83 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Lesokhin for performance year 2024, reported as part of a group. Dr. Lesokhin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lesokhin as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Lesokhin's MIPS scores, performance year 2024
- 83of 100Final score
- 80.3of 100Quality
- 40of 100Improvement Activities
- 62of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Alexander M. Lesokhin has 143 publications on record
Dmand AI links 143 papers to Dr. Lesokhin, published from 2009 to 2025. 2016 was the busiest year, with 18. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal. Dr. Lesokhin has published most often in Blood. Dr. Lesokhin's most frequent co-authors are Hani Hassoun, MD, Sergio A. Giralt, MD and Sham Mailankody, MBBS.
Dr. Lesokhin's papers by year, 2016 to 2025
Topics Dr. Lesokhin writes about most
- Multiple Myeloma
- Antineoplastic Combined Chemotherapy Protocols
- Antibodies, Monoclonal
- Lenalidomide
- Dexamethasone
- Hematopoietic Stem Cell Transplantation
- Antibodies, Monoclonal, Humanized
- Immunotherapy, Adoptive
Dr. Lesokhin's most frequent co-authors
- Hani Hassoun, MD57 shared papers
- Sergio A. Giralt, MD50 shared papers
- Sham Mailankody, MBBS42 shared papers
Recent publications by Dr. Lesokhin
See who Dr. Lesokhin researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lesokhin works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Alexander M. Lesokhin has worked on 9 clinical trials
Dmand AI links Dr. Lesokhin to 9 clinical trials, 4 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Diabetes Mellitus, Insulin-Dependent, 12. Memorial Sloan Kettering Cancer Center sponsors the most, 4. Open Payments lists research payments to Dr. Lesokhin that name 2 trials.
Clinical trials with Dr. Lesokhin by phase
- 4Phase 1: 4 trials
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Lesokhin's trials
- Multiple Myeloma
- Blood Protein Disorders
- Diabetes Mellitus, Insulin-Dependent, 12
- Diarrhea
- Lymphoma
Investigators on the most trials with Dr. Lesokhin
- Al-Ola A. Abdallah, MD1 shared trial
- Rachid C. Baz, MD1 shared trial
- Don Michael Benson, MD1 shared trial
Recent clinical trials with Dr. Lesokhin
A Study of TTI-622 in Combination With Daratumumab Hyaluronidase-fihj in People With Multiple Myeloma (opens in a new tab)
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission (opens in a new tab)
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Alexander M. Lesokhin received $94,592 in industry payments from 2016 to 2025
CMS Open Payments shows 135 general payments to Dr. Lesokhin from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Pfizer Inc. paid the most, $39,519. It also lists 80 research payments totaling $391,870 from 2016 to 2025, naming 2 clinical trials.
General payments to Dr. Lesokhin by program year, 2016 to 2025
General payments to Dr. Lesokhin by kind, 2016 to 2025
- Consulting fees$66,13670%
- Speaker and faculty fees$9,39010%
- Travel and lodging$8,1839%
- Honoraria$7,9508%
- Other$2,9333%
Companies that paid Dr. Lesokhin the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Alexander M. Lesokhin graduated from Albert Einstein College of Medicine
Dr. Lesokhin graduated from Albert Einstein College of Medicine in 2002.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Alexander M. Lesokhin accepts plans from 13 insurance carriers
Dr. Lesokhin is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
- Aetna
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- HCSC
- MVP Health Care
- Regence Health Plans
- +5 more carriersWith a free account
Plan types Dr. Lesokhin accepts, by number of carriers
- PPO9
- Medicare8
- POS5
- EPO4
- HMO4
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Alexander M. Lesokhin's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Alexander M. Lesokhin
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Alexander M. Lesokhin's NPI number?
Dr. Alexander M. Lesokhin's NPI number is 1790950863. It was assigned on April 29, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Alexander M. Lesokhin?
Dr. Alexander M. Lesokhin is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Alexander M. Lesokhin practice?
Dr. Lesokhin practices at 1275 York Avenue, New York, NY 10065. Dr. Lesokhin's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Lesokhin to 2 medical groups.
What is Dr. Alexander M. Lesokhin's medical license number?
Dr. Lesokhin holds New York license 231760, one of the licenses on file in 4 states.
Which states has Dr. Alexander M. Lesokhin been licensed in?
Dmand AI has state licenses on file for Dr. Lesokhin in New York (2004 to 2027), Florida (since 2021), New Jersey (2020 to 2027) and North Carolina (2020 to 2022).
Which hospitals is Dr. Alexander M. Lesokhin affiliated with?
Dr. Lesokhin practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Alexander M. Lesokhin part of?
Dr. Lesokhin is linked to Memorial Hematology Lymphoma Group. Dmand AI links Dr. Lesokhin to 2 more medical groups.
Does Dr. Alexander M. Lesokhin accept Medicare?
Yes. CMS data shows Dr. Lesokhin billed Medicare for 900 services in 2024, and Dr. Lesokhin accepts Medicare assignment.
Does Dr. Alexander M. Lesokhin offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Lesokhin as offering telehealth services.
What is Dr. Alexander M. Lesokhin's MIPS score?
Dr. Lesokhin's MIPS final score for performance year 2024 is 83 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Alexander M. Lesokhin see?
CMS counts 241 Medicare patients who saw Dr. Lesokhin in 2024, with an average age of 75.
Is Dr. Alexander M. Lesokhin board certified?
Yes. Dr. Lesokhin is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Alexander M. Lesokhin bill to Medicare?
In 2024, Dr. Lesokhin's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99233).
Where did Dr. Alexander M. Lesokhin go to medical school?
Dr. Lesokhin graduated from Albert Einstein College of Medicine in 2002.
What drugs does Dr. Alexander M. Lesokhin prescribe most?
In 2024 Medicare Part D data, Dr. Lesokhin's most prescribed drugs by claims were Acyclovir, Lenalidomide and Omeprazole.
Has Dr. Alexander M. Lesokhin received payments from drug or device companies?
CMS Open Payments shows $94,592 in general payments to Dr. Lesokhin from 13 companies from 2016 to 2025. The largest total came from Pfizer Inc.
How long has Dr. Alexander M. Lesokhin been practicing?
Dr. Lesokhin graduated from medical school in 2002, 24 years ago.
Does Dr. Alexander M. Lesokhin do research?
Dmand AI links 143 publications to Dr. Lesokhin, published from 2009 to 2025. Dr. Lesokhin has worked on 9 clinical trials.
Who does Dr. Alexander M. Lesokhin publish with?
Dr. Lesokhin's most frequent co-authors are Hani Hassoun, MD (57 shared papers), Sergio A. Giralt, MD (50 shared papers) and Sham Mailankody, MBBS (42 shared papers).
What insurance does Dr. Alexander M. Lesokhin accept?
Dr. Lesokhin is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card